NO2929506T3 - - Google Patents

Info

Publication number
NO2929506T3
NO2929506T3 NO13805681A NO13805681A NO2929506T3 NO 2929506 T3 NO2929506 T3 NO 2929506T3 NO 13805681 A NO13805681 A NO 13805681A NO 13805681 A NO13805681 A NO 13805681A NO 2929506 T3 NO2929506 T3 NO 2929506T3
Authority
NO
Norway
Application number
NO13805681A
Other languages
Norwegian (no)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47682064&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO2929506(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of NO2929506T3 publication Critical patent/NO2929506T3/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5058—Neurological cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5073—Stem cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Developmental Biology & Embryology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO13805681A 2012-02-29 2013-11-26 NO2929506T3 (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13/408,485 US20130224782A1 (en) 2012-02-29 2012-02-29 Neurogenesis screening method and system using adipose tissue derived stem cells

Publications (1)

Publication Number Publication Date
NO2929506T3 true NO2929506T3 (zh) 2018-03-10

Family

ID=47682064

Family Applications (1)

Application Number Title Priority Date Filing Date
NO13805681A NO2929506T3 (zh) 2012-02-29 2013-11-26

Country Status (19)

Country Link
US (1) US20130224782A1 (zh)
EP (1) EP2820415B1 (zh)
CN (1) CN104285147B (zh)
AR (1) AR089987A1 (zh)
BR (1) BR112014019902A8 (zh)
CA (1) CA2865735A1 (zh)
ES (1) ES2643555T3 (zh)
HK (1) HK1206098A1 (zh)
IN (1) IN2014DN05638A (zh)
MX (1) MX357503B (zh)
MY (1) MY167127A (zh)
NO (1) NO2929506T3 (zh)
PE (1) PE20142280A1 (zh)
PH (1) PH12014501945A1 (zh)
PL (1) PL2820415T3 (zh)
RU (1) RU2014132220A (zh)
SG (1) SG11201403789SA (zh)
TW (1) TWI613446B (zh)
WO (1) WO2013130196A1 (zh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015050744A2 (en) * 2013-10-03 2015-04-09 Mjn U.S. Holdings Llc Neurogenesis screening method and uses thereof
US20200208103A1 (en) * 2017-07-20 2020-07-02 Riken Method for maturation of retinal tissue containing continuous epithelium

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070015138A1 (en) * 2005-07-08 2007-01-18 Braincells, Inc. Methods for identifying agents and conditions that modulate neurogenesis
CN101117625B (zh) * 2007-07-12 2010-08-04 中国人民解放军军事医学科学院野战输血研究所 诱导间充质干细胞和脂肪干细胞分化为神经元的方法
JP5393119B2 (ja) * 2008-12-05 2014-01-22 日本メナード化粧品株式会社 幹細胞の褐色脂肪細胞への分化誘導方法
WO2011050476A1 (en) * 2009-10-31 2011-05-05 New World Laboratories Inc . Methods for reprogramming cells and uses thereof

Also Published As

Publication number Publication date
AR089987A1 (es) 2014-10-01
IN2014DN05638A (zh) 2015-04-03
EP2820415A1 (en) 2015-01-07
PE20142280A1 (es) 2015-01-23
MX357503B (es) 2018-07-12
MX2014009489A (es) 2014-09-11
ES2643555T3 (es) 2017-11-23
HK1206098A1 (zh) 2015-12-31
SG11201403789SA (en) 2014-08-28
RU2014132220A (ru) 2016-04-20
US20130224782A1 (en) 2013-08-29
WO2013130196A1 (en) 2013-09-06
MY167127A (en) 2018-08-13
CN104285147B (zh) 2017-10-27
TWI613446B (zh) 2018-02-01
TW201346082A (zh) 2013-11-16
CN104285147A (zh) 2015-01-14
BR112014019902A8 (pt) 2017-07-11
EP2820415B1 (en) 2017-07-26
CA2865735A1 (en) 2013-09-06
PH12014501945A1 (en) 2014-11-24
PL2820415T3 (pl) 2017-12-29
BR112014019902A2 (zh) 2017-06-20

Similar Documents

Publication Publication Date Title
BR112014019566A2 (zh)
BR112014017635A2 (zh)
BR112014017614A2 (zh)
BR112014017625A2 (zh)
BR112014017659A2 (zh)
BR112014017646A2 (zh)
BR112014017638A2 (zh)
BR112014017607A2 (zh)
BR112014018017A2 (zh)
BR112013027865A2 (zh)
BR112014017801A2 (zh)
BR112014017634A2 (zh)
BR112014017609A2 (zh)
BR112014017644A2 (zh)
BR112014017647A2 (zh)
BR112014017618A2 (zh)
BR112014013184A8 (zh)
BR112014017630A2 (zh)
BR112014017652A2 (zh)
BR112014017621A2 (zh)
BR112014017627A2 (zh)
BR112014017623A2 (zh)
BR112014017622A2 (zh)
BR112014017641A2 (zh)
BR112014017631A2 (zh)